Shanghai - Delayed Quote CNY

Guangdong Marubi Biotechnology Co., Ltd. (603983.SS)

28.29 +0.35 (+1.25%)
At close: 3:00 PM GMT+8
Loading Chart for 603983.SS
DELL
  • Previous Close 27.94
  • Open 27.85
  • Bid 28.29 x --
  • Ask 28.30 x --
  • Day's Range 27.21 - 28.38
  • 52 Week Range 22.96 - 41.30
  • Volume 2,430,137
  • Avg. Volume 2,708,376
  • Market Cap (intraday) 11.344B
  • Beta (5Y Monthly) 0.14
  • PE Ratio (TTM) 50.52
  • EPS (TTM) 0.56
  • Earnings Date --
  • Forward Dividend & Yield 0.25 (0.89%)
  • Ex-Dividend Date Jul 19, 2023
  • 1y Target Est 29.82

Guangdong Marubi Biotechnology Co., Ltd. engages in the research and development, design, production, sale, and service of various cosmetics in China. The company provides skin care, make up, and eye care products. It offers its products under the Marubi, Lianhuo, Chunji, and the Love Fire brand names. The company was founded in 2002 and is based in Guangzhou, China.

www.marubi.cn

1,060

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: 603983.SS

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

603983.SS
11.95%
SSE Composite Index
3.82%

1-Year Return

603983.SS
15.82%
SSE Composite Index
5.40%

3-Year Return

603983.SS
48.14%
SSE Composite Index
11.10%

5-Year Return

603983.SS
--
SSE Composite Index
5.15%

Compare To: 603983.SS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 603983.SS

Valuation Measures

Annual
As of 4/25/2024
  • Market Cap

    11.20B

  • Enterprise Value

    10.22B

  • Trailing P/E

    49.89

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.37

  • Price/Book (mrq)

    3.44

  • Enterprise Value/Revenue

    4.81

  • Enterprise Value/EBITDA

    39.85

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    10.73%

  • Return on Assets (ttm)

    3.01%

  • Return on Equity (ttm)

    6.96%

  • Revenue (ttm)

    2.12B

  • Net Income Avi to Common (ttm)

    228M

  • Diluted EPS (ttm)

    0.56

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.24B

  • Total Debt/Equity (mrq)

    3.23%

  • Levered Free Cash Flow (ttm)

    -304.78M

Research Analysis: 603983.SS

Analyst Price Targets

22.00 Low
29.82 Average
28.29 Current
39.30 High
 

Earnings

Consensus EPS
 

Company Insights: 603983.SS

People Also Watch